Clinical Trials Directory

Trials / Unknown

UnknownNCT05455437

Monitoring and Evaluation Study of Project ECHO for ILD

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Pulmonary Care and Research Collaborative Limited · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The study will utilize pre-post survey measures to evaluate Project ECHO for ILD with respect to an initial set of practice and clinical outcomes and relies on questionnaire data obtained from providers participating in Project ECHO for ILD at baseline, at 6 months, and at study end.

Detailed description

Project ECHO (Extension for Community Healthcare Outcomes) is a knowledge-sharing model to expand the capacity of the health care workforce so that more people can get high quality care for their health conditions in or near the communities where they live. The model brings specialty disease expertise to community providers through its hub-and-spoke networks. The model relies on videoconferencing to connect local providers in non-urban or underserved communities (spoke sites) with an interdisciplinary team of specialist providers at academic medical centers (hubs) during virtual "teleECHO" clinic sessions, which include brief educational lectures and case-based, experiential learning. It is a guided, technology-enabled collaborative practice model in which community providers become experts in an area of community need within the scope of their practice, operating with increasing independence as their skills and self-efficacy grow. The model establishes meaningful, ongoing relationships with hub specialists who serve as telementors for spoke providers and relies on case-based learning from presentations of real-world de-identified patient cases. The overarching goal of the project is to implement and evaluate an adaptation of the ECHO model to interstitial lung disease (ILD) diagnosis and care among primary care physicians (PCPs) and community pulmonologists in non-urban or underserved communities.

Conditions

Timeline

Start date
2022-07-01
Primary completion
2023-12-01
Completion
2024-03-01
First posted
2022-07-13
Last updated
2022-07-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05455437. Inclusion in this directory is not an endorsement.